November 2018, Scrip White Paper
There is no longer any excuse not to include Japan as an integral part of any global clinical-development program for either pharmaceuticals or medical devices. With a more receptive climate for both starting and running trials, an improved infrastructure for clinical research, and significant advances in accelerating drug approvals, Japan is now firmly on the global development map.
Click here and read this whitepaper which discusses how to run successful clinical trials in Japan.
- Regulatory and operating environment changes
- Flexible conditions for clinical trials
- Scheduling clinical trials in Japan
- Investigator, patient commitment to clinical trials
- And much more